This page shows the latest Intra-Cellular Therapeutics news and features for those working in and with pharma, biotech and healthcare.
Shares rocketed following the announcement. US biotech Intra-Cellular Therapeutics has scored approval for its antipsychotic drug Caplyta for the treatment of schizophrenia, to the delight of investors. ... The approval is an early Christmas present for
Says lumateperone could provide additional benefits over existing treatments. US biotech company Intra-Cellular Therapies says it could file its lead drug lumateperone for schizophrenia as early as next year after ... Intra-Cellular maintains this
More from news
Approximately 2 fully matching, plus 0 partially matching documents found.
More recently Sir Michael has served on the board of US-based biotech Intra-Cellular Therapeutics.
Sir Michael Rawlins joins board of Intra-Cellular Therapeutics. The former chair of England's cost-effectiveness body for medicines, Sir Michael Rawlins, has made a contentious move to the US ... His expertise in the cost-effectiveness of new
More from appointments
Approximately 1 fully matching, plus 1 partially matching documents found.
Research Partnership is now a member of Inizio Advisory, the consulting business unit of Inizio, a strategic partner for health...